Pharma Business Daily
Claim your FREE trial subscription!


Prescription Medicines:

Opportunities in Drug Delivery - Identifying hot technologies, companies and markets (report)

Urch Publishing
Management Report  October 2003

Paper - USD 1475.00  
Single-user PDF - USD 1625.00  


http://www.pharmsinfo.com/bulletin_graphics/Urch_report.jpeg

The formulation and delivery of drugs have played a crucial role in the development and commercialisation of pharmaceutical products during the last decade and none of the most commercially successful drugs have escaped the attention of companies wishing to improve convenience of their delivery to the patient. Drug delivery will play an increasingly important role in the next decade as more macromolecules including proteins, peptides and oligonucleotides find their way to the market.

The formulation and delivery of drugs have played a crucial role in the development and commercialisation of pharmaceutical products during the last decade and none of the most commercially successful drugs have escaped the attention of companies wishing to improve convenience of their delivery to the patient. Drug delivery will play an increasingly important role in the next decade as more macromolecules including proteins, peptides and oligonucleotides find their way to the market.

Brief Scope of this report

  • Identifies new opportunities for drug delivery companies and provides a summary of the developments associated with new delivery systems for the top selling drugs and macromolecules.

  • Reviews developments in novel delivery of top-selling polypeptides and proteins, macromolecules, which have also traditionally presented significant problems in terms of delivery to the patient.With increased current interest in alternative systems to oral and parenteral drug delivery, the report describes novel systems used for inhaled (pulmonary) and nasal delivery of drugs as well novel oral systems, transdermal and depot parenteral systems.

  • Profiles of companies specialising in drug delivery have been included, which focus on their technology and how it is being applied to improve delivery of small and macromolecules.

    Author Dr Brian Minter is the Managing Director of Chembio, a consultancy in the fields of fine chemicals and pharmaceutical businesses. Dr Minter is an author of a number of commercial publications on Cancer Therapy, Drug Delivery Systems and Reformulation Strategies. Prior to Chembio, Dr Minter has worked as a research biochemist at Pfizer (UK), as scientific editor for Biochimica Biophysica Acta (Elsevier Scientific Publications) in The Netherlands and as marketing manager of fine chemical intermediates for drug active production at DSM and Solvay Pharmaceuticals as well as drug and medical device registration at this same company. Dr Minter lives in The Netherlands.





    • For full details, please email jenniferc@cmsinfo.com

    Order Form



    CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
    Tel:     +44 (0)1494 771734
    Fax:   +44 (0)1494 778994
    e-mail: Jennifer Cowlard
    copyright © 2008 all rights reserved

    For more information about us, visit CMSinfo.

    footer bar